Michaela J. Higgins - Concepedia

Author

Michaela J. Higgins

Also Known As

M Higgins, M J Higgins, M. Higgins, M. J. Higgins, M.J. Higgins, Michael J Samson, Michaela Higgins, Michaela J Higgins, Michaela J. Higgins, Michaela Jane Higgins

127

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute

About

Michaela J. Higgins is an author at Johns Hopkins University specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.1K
2	Cell Biology	4	4	347
3	Health Sciences	1	1	32
4	Public Health	1	1	496
5	Global Health	1	1	496

Michaela J. Higgins

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Planning cancer control in Latin America and the Caribbean Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, The Lancet Oncology Preventive MedicineMedicineGlobal HealthEpidemiology Of CancerCancer Prevention	2013	496
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, Clinical Cancer Research	2014	392
Detection of Tumor <i>PIK3CA</i> Status in Metastatic Breast Cancer Using Peripheral Blood Michaela J. Higgins, Danijela Jelovac, Evan Barnathan, Clinical Cancer Research	2012	305
Knockin of mutant PIK3CA activates multiple oncogenic pathways John P. Gustin, Bedri Karakas, Michele B. Weiss, Proceedings of the National Academy of Sciences Human BreastCancer ResearchSignal TransductionMutant Pik3caSignaling Pathway	2009	173
Mutation of a single allele of the cancer susceptibility gene <i>BRCA1</i> leads to genomic instability in human breast epithelial cells Hiroyuki Konishi, Morassa Mohseni, Akina Tamaki, Proceedings of the National Academy of Sciences	2011	163
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial Nadia Harbeck, Eva Ciruelos, Guy Jérusalem, Nature Medicine	2024	141
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients Sara M. Tolaney, David R. Ziehr, Hao Guo, The Oncologist	2016	110
Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells Emma Kavanagh, Sinéad Lindsay, Melinda Halász, Oncogenesis Breast OncologyNanotherapeuticsExtracellular MicrovesiclesImmunotherapeuticsCancer Biology	2017	102
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, The Oncologist	2016	76
Isocitrate Dehydrogenase 1 (<i>IDH1</i>) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate Amir T. Fathi, Hossein Sadrzadeh, Amy Comander, The Oncologist	2014	74

Page 1